Avsnittsbeskrivning
In this episode of BJD Talks, Sam and Meera discuss the article ‘Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials ’ by Stein Gold et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag264 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

